Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Diabetic Eye Screening Programme

  • First published: 29 September 2018
  • Last modified: 29 September 2018

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
Greater Manchester Health and Social Care Partnership
Authority ID:
AA71813
Publication date:
29 September 2018
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

The service will reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process.

This will be achieved by delivering evidence-based, and population-based screening programmes that:

— identify the eligible population and ensure effective delivery with maximum coverage,

— are safe, effective, of a high quality, externally and independently monitored, and quality assured,

— lead to earlier detection, appropriate referral, effective treatment and improved outcomes,

— are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuing Medical Education (CME), Continuous Professional Development (CPD), and Quality Assurance (QA) schemes; and

— have audit embedded in the service.

The contract term is for an initial period of 3 years with the option to extend the contract by a further 24 months at the discretion of the Contracting Authority and subject to satisfactory contractual and financial performance.

Full notice text

Social and other specific services – public contracts

Contract award notice

Section I: Contracting authority

I.1) Name and addresses

NHS England North (Greater Manchester Health and Social Care Partnership)

4th Floor, 3 Piccadilly Place

Manchester

M1 3BN

UK

E-mail: necsu.neprocurement@nhs.net

NUTS: UK

Internet address(es)

Main address: http://www.england.nhs.uk

Address of the buyer profile: https://www.proactisplaza.com/SupplierPortal/?CID=NECS

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Diabetic Eye Screening Programme

Reference number: NHSE282

II.1.2) Main CPV code

85100000

 

II.1.3) Type of contract

Services

II.1.4) Short description

North of England Commissioning Support (NECS) is a commissioning support service hosted by NHS England and is managing this procurement process for and on behalf of Greater Manchester Health and Social Care Partnership. Who have commissioned a Diabetic Eye Screening Programme in Greater Manchester covering 2 Lots:

Lot 1 Greater Manchester North,

Lot 2 Greater Manchester South.

II.1.6) Information about lots

This contract is divided into lots: Yes

II.1.7) Total value of the procurement

Value excluding VAT: 23 000 000.00  GBP

II.2) Description

Lot No: 1

II.2.1) Title

Diabetic Eye Screening — North Manchester

II.2.2) Additional CPV code(s)

85100000

85323000

II.2.3) Place of performance

NUTS code:

UKD3


Main site or place of performance:

Greater Manchester North covers the following CCG areas:

Bolton;

Wigan Borough;

Bury;

Heywood, Middleton and Rochdale; and

Oldham.

II.2.4) Description of the procurement

The service will reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process.

This will be achieved by delivering evidence-based, and population-based screening programmes that:

— identify the eligible population and ensure effective delivery with maximum coverage,

— are safe, effective, of a high quality, externally and independently monitored, and quality assured,

— lead to earlier detection, appropriate referral, effective treatment and improved outcomes,

— are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuing Medical Education (CME), Continuous Professional Development (CPD), and Quality Assurance (QA) schemes; and

— have audit embedded in the service.

The contract term is for an initial period of 3 years with the option to extend the contract by a further 24 months at the discretion of the Contracting Authority and subject to satisfactory contractual and financial performance.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 2

II.2.1) Title

Diabetic Eye Screening — South Manchester

II.2.2) Additional CPV code(s)

85100000

85323000

II.2.3) Place of performance

NUTS code:

UKD3


Main site or place of performance:

Greater Manchester South cover the following CCG areas:

Trafford CCG,

Manchester CCG,

Salford CCG,

Stockport CCG,

Tameside and Glossop CCG.

II.2.4) Description of the procurement

The service will reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process.

This will be achieved by delivering evidence-based, and population-based screening programmes that:

— identify the eligible population and ensure effective delivery with maximum coverage,

— are safe, effective, of a high quality, externally and independently monitored, and quality assured,

— lead to earlier detection, appropriate referral, effective treatment and improved outcomes,

— are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuing Medical Education (CME), Continuous Professional Development (CPD), and Quality Assurance (QA) schemes; and

— have audit embedded in the service.

The contract term is for an initial period of 3 years with the option to extend the contract by a further 24 months at the discretion of the Contracting Authority and subject to satisfactory contractual and financial performance.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.10) Identification of the national rules applicable to the procedure:

Information about national procedures is available at: (URL)

http://www.legislation.gov.uk/uksi/2015/102/pdfs/uksi_20150102_en.pdf

IV.1.11) Main features of the award procedure:

As per the Tender Documentation.

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2018/S 112-255762

Section V: Award of contract

Lot No: 1

Title: Diabetic Eye Screening — North Manchester

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

24/08/2018

V.2.2) Information about tenders

Number of tenders received: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Health Intelligence Ltd

Saxon House

Sandbach

CW11 3HL

UK

NUTS: UKD6

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 11 200 000.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 2

Title: Diabetic Eye Screening — South Manchester

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

18/09/2018

V.2.2) Information about tenders

Number of tenders received: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Health Intelligence Ltd

Saxon House

Sandbach

CW11 3HL

UK

NUTS: UKD6

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 11 800 000.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

(MT Ref:213341)

VI.4) Procedures for review

VI.4.1) Review body

North of England Commissioning Support Unit

Teesdale House, Thornaby

Stockton on Tees

TS17 6BL

UK

E-mail: necsu.neprocurement@nhs.net

Internet address(es)

URL: http://www.necsu.nhs.uk

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

The Commissioner will act in accordance with Part 3 Chapter 5 Regulation 85 to 87 and Part 3 Chapter 6Regulation 88 to 104 of the Public Contract Regulations 2015 (SI 2015 No 102) (PCR 2015). Part 3 of thePCR 2015 provides for appeals to be made to the High Court subject to the time limitations and other requiredprocedural steps. The rules relating to appeal are complex and a dissatisfied tenderer is advised to take theirown prompt legal advice.

VI.4.4) Service from which information about the review procedure may be obtained

Royal Courts of Justice

Strand

London

WC2A 2LL

UK

Internet address(es)

URL: https://courttribunalfinder.service.gov.uk/courts/royal-courts-of-justice

VI.5) Date of dispatch of this notice

24/09/2018

Coding

Commodity categories

ID Title Parent category
85323000 Community health services Social services
85100000 Health services Health and social work services

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
necsu.neprocurement@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.